Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,307 total articles
Director Anthony S. Colavita bought 684 shares of Gabelli Dividend & Income Trust (NYSE: GDV) on February 9, 2026, for a total of $19,969, according to a Form 4 filed with the SEC. Separately, the fund amended its Statement of Preferences to authorize 10 million additional Series M Preferred Shares, increasing the total authorized to 30 million, an…
ResMed Chairman and CEO Michael J. Farrell sold 4,991 shares on February 9, 2026, for about $1.36 million at a weighted average price of $273.7801. The same day he exercised options to acquire 4,991 shares at $146.34, for $730,382. The transactions were made under a Rule 10b5-1 plan adopted October 31, 2024. Filings show he retains substantial dire…
Raymond D. Cabrera, senior vice president and chief human resources officer at Knowles Corp (NYSE: KN), sold 10,000 shares on Feb. 9, 2026 for $26.75 per share, generating $267,500 in proceeds. The company has reported stronger-than-expected fourth-quarter results and received an analyst reiteration, while valuation metrics from InvestingPro flag t…
Daniel J. Giesecke, Senior Vice President and Chief Operating Officer of Knowles Corp, executed two recent stock dispositions totaling 19,217 shares to cover tax obligations and for open-market sale, while the company reported Q4 2025 results that exceeded analyst forecasts and received an Outperform reaffirmation from Baird.
Bankwell Financial Group Executive Vice President and Chief Financial Officer Courtney E. Sacchetti sold 1,062 shares of the company’s common stock on February 9, 2026, for $52,876, while also receiving granted shares the same day. The regional bank reported fourth-quarter 2025 results that surpassed analyst projections on both EPS and revenue, tho…
Angelo G. Fusaro, Principal Accounting Officer at Bankwell Financial Group, Inc. (NASDAQ:BWFG), sold 316 shares on February 9, 2026 for $49.88 per share, totaling $15,762, and in the same Form 4 reported receipt of 414 shares granted under the 2022 Stock Plan at a $0 price. Bankwell posted fourth-quarter 2025 results that exceeded analyst expectati…
Bankwell Financial Group Executive Vice President and Chief Credit Officer Christine Chivily sold 1,985 shares on February 9, 2026, for about $98,853, with sale prices between $49.38 and $50.15. That same day she is also reported to have acquired 2,635 shares with a total value of $0 at a price of $0. Separately, Bankwell posted fourth-quarter 2025…
Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp (TPL), recorded the purchase of a single share on February 9, 2026 at $371.57. The firm now directly holds 3,479,369 shares. Meanwhile, Texas Pacific Land disclosed a partnership with Bolt Data & Energy to develop large-scale data center campuses on its holdings,…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (RCG), reported purchases of the fund's common stock on February 9, 2026. Stahl and affiliated parties acquired 1,134 shares at $2.68 per share, totaling $3,039, while the fund trades at $2.71 and shows a low P/E and notable revenue growth per InvestingPro data.
Lucky Strike Entertainment Corp director John Alan Young purchased 6,000 Class A common shares on February 6, 2026, spending $39,000. The transaction comes as the stock sits close to its 52-week low and follows continued management buybacks. Multiple brokerages reaffirm Buy ratings and maintain price targets above current trading levels, and the co…
Syndax Pharmaceuticals Chief Financial Officer Keith A. Goldan sold 3,410 shares of common stock on February 9, 2026, at $21.028 per share to satisfy tax withholding related to vested restricted stock units. The transaction reduced a portion of his holdings while leaving him with 140,429 shares. The company recently showcased positive clinical resu…
Syndax Pharmaceuticals Chief Executive Officer Michael A. Metzger sold 17,159 shares on February 9, 2026, at $21.028 per share to meet tax withholding obligations tied to vesting restricted stock units. The transaction reduced no material ownership contextually; Metzger still holds 491,690 shares as the company draws positive analyst attention and …
Robert A. Schriesheim, a member of the board at Houlihan Lokey, sold 5,000 shares of Class A Common Stock at $170.86 per share on February 6, 2026, generating proceeds of $854,300. The transaction was disclosed in a Form 4 filed with the SEC on February 10, 2026. Separately, Houlihan Lokey reported fiscal third-quarter adjusted EPS of $1.94 and rev…
Merchants Bancorp Chairman and CEO Michael F. Petrie sold 21,759 Series C Depositary Shares across two trades in early February 2026, raising $439,531. The sales occurred as the stock traded near its 52-week high and after strong recent returns. Separately, the company’s board approved a $100 million repurchase program that runs through December 31…
A Ralliant Corp director filed a Form 4 disclosing a purchase of 2,000 common shares on February 9, 2026, at $41.25 per share, a transaction totaling $82,500. The buy comes after the stock fell about 24.76% over the prior week. The company disclosed a $1.44 billion goodwill impairment tied to its EA Elektro-Automatik business and trimmed 2026 guida…
Caterpillar Group President Bob De Lange executed option exercises and sold company stock on February 6, 2026, netting approximately $16.3 million from the sale of 22,656 shares. The moves followed the exercise of options to acquire 28,034 shares and occurred amid a fourth-quarter 2025 results beat in both earnings per share and revenue.
Director John B. Hansen sold 1,000 shares of Mueller Industries (MLI) on February 9, 2026, in a transaction valued at $116,710. The sale leaves Hansen with 90,664 directly held shares and 15,000 additional shares held indirectly through a family trust. Mueller reported fourth-quarter 2025 revenue growth alongside margin contraction and drew a price…
Lam Research director Eric Brandt sold 35,000 shares of the company's common stock on February 6, 2026, in two transactions totaling $7.8 million, according to a Form 4 filing. The semiconductor equipment maker recently posted fiscal second-quarter 2026 results that topped consensus, prompting analyst target increases, while also announcing executi…
Woodward director Eileen P. Paterson sold 5,200 shares of the company on February 5, 2026, for roughly $1.96 million and exercised options to acquire the same number of shares at $79.81. The moves coincided with the company reporting fiscal 2026 first-quarter earnings and revenues that surpassed analyst forecasts, and with shareholder approval of t…
Charles R. Guthrie, Vice Chairman of the Board of CB Financial Services (NASDAQ: CBFV), sold 1,913 shares of common stock on February 6, 2026, for roughly $71,450 and on the same day executed stock options to acquire 2,515 shares valued at $71,316. After these moves, Guthrie holds 16,796 shares directly and 6,901 shares indirectly. The bank reporte…
Automatic Data Processing Executive Vice President Brian L. Michaud sold 1,000 shares on February 6, 2026, under a pre-arranged Rule 10b5-1 plan adopted in September 2025, receiving $234.18 per share for proceeds of $234,180. The transaction leaves Michaud with 15,310.3519 shares directly. Separately, ADP reported fiscal Q2 2026 results that exceed…
John Rodney Messick, a director at Orrstown Financial Services, sold 2,500 shares on February 5, 2026, generating $96,550. The company reported fourth-quarter 2025 results that topped analyst estimates for both EPS and revenue, yet the stock fell in after-hours trading. Messick retains both immediately held common shares and restricted shares that …
Independent Bank Corp director John J. Morrissey sold 1,988 shares on February 6, 2026, for $85.70 each, netting $170,371. After the sale, Morrissey holds 12,747.078 shares, a total that includes 376.6224 shares accumulated through the company dividend reinvestment and stock purchase plan. The bank reported fourth-quarter 2025 results that exceeded…
SFS Holding Corp, a 10% owner of UWM Holdings Corp, sold 1,898,622 Class A shares from Feb. 5-9, 2026 under a pre-arranged 10b5-1 plan for roughly $9.2 million. The disposition occurred in three trades at $4.61 to $5.18 per share. After the sales SFS directly holds 3,692,273 shares. UWM’s stock has slid 8.86% over the prior week and is trading at $…
Spero Therapeutics' Chief Operating Officer Timothy Keutzer sold 18,652 shares on February 6, 2026 to satisfy tax-withholding obligations arising from RSU vesting. The company also disclosed a board departure, an agreement to retain the departing director as a consultant, the conclusion of an SEC inquiry with no enforcement action currently planned…
